Edith Mitchell Named President of the National Medical Association

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

EDITH MITCHELL was named president of the National Medical Association, at the organization’s 113th annual convention and scientific assembly in Detroit Aug 4. Mitchell is a professor of medical oncology at Thomas Jefferson University.

“I am deeply honored to have been appointed as president-elect of this prestigious organization,” said Mitchell Aug. 3, who is also the program leader of Gastrointestinal Oncology and associate director for diversity programs at Thomas Jefferson University.

“There is still much work to be done with regards to disparities in medical treatment. I believe that we can all work together and make great strides to address barriers in helping underserved populations get better care and lead to better health care in our nation.”

The NMA is the nation’s oldest and largest professional society for African American physicians. One of its mission statements is to support and increase the representation and contributions of people of African descent by helping shape policy, through educational programs, and community outreach.

Mitchell’s work has focused on groups whose medical needs have not been met by medical system in the United States. As a practicing medical oncologist, her research interests have included many cancer types such as breast, colorectal, pancreatic and other gastrointestinal malignancies.

In 2008, she received the Tree of Life award from the Wellness of You organization, a Philadelphia nonprofit providing health education and resources to the community, in recognition of her efforts in health management in the local and global community.

She was recognized for her commitment to diversity, research, and education in 2009 by the American Cancer Society’s Cancer Control Award.

Mitchell is also a retired brigadier general in the U.S. Air Force, and was the first female physician to attain this rank. She served as senior medical Air National Guard advisor to the command surgeon and was the medical liaison between the active Air Force and the Air National Guard.

YOU MAY BE INTERESTED IN

For nearly 25 years, business executive Lou Weisbach and urologist Richard J. Boxer have argued that finding the money to finance the cures for devastating diseases is not as difficult as it appears. To start finding the cures, the U.S. Department of the Treasury needs to issue some bonds—$750 billion worth. Next, you hire CEOs—one...

There is general agreement that the United States spends too much on health care, especially on pharmaceuticals.  But what we spend on drugs is not simply a function of price. If eggs double in price, people can simply cut the number of eggs they eat in half.  Simply stated, cost is the product of (price per unit times the number of units purchased). 
What did President Richard M. Nixon and Senator Edward M. Kennedy have in common? They each played a pivotal role in the passage of the National Cancer Act signed by Nixon on Dec. 23, 1971. The NCA established the National Cancer Program authorizing the initial investment in the NCI-designated Cancer Centers Program. 
When I first proposed targeting PCNA (proliferating cell nuclear antigen) as a therapeutic approach, the response I got was: “No one will ever make a drug against PCNA. It’s undruggable.” The protein lacks enzymatic activity, has a disordered region, and binds to over 200 other proteins within the cell. From a traditional drug development perspective, these characteristics made PCNA an impossible target.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login